Detalhe da pesquisa
1.
Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis.
Antimicrob Agents Chemother
; 63(6)2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30936097
2.
Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer.
Antimicrob Agents Chemother
; 63(3)2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559131
3.
High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease.
Antimicrob Agents Chemother
; 63(2)2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30455239
4.
Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
Antimicrob Agents Chemother
; 62(7)2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29735562
5.
Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.
Proc Natl Acad Sci U S A
; 112(3): 869-74, 2015 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25561537
6.
Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo.
J Antimicrob Chemother
; 72(2): 455-461, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27798204
7.
Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.
Antimicrob Agents Chemother
; 60(5): 2864-9, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26926638
8.
Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations.
Antimicrob Agents Chemother
; 59(4): 2129-35, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25624335
9.
Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis.
Antimicrob Agents Chemother
; 59(6): 3042-51, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25753644
10.
Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis.
Am J Respir Crit Care Med
; 188(1): 97-102, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23593945
11.
Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice.
Am J Respir Crit Care Med
; 188(5): 608-12, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23822735
12.
Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy.
J Antimicrob Chemother
; 68(3): 659-65, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23129730
13.
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
Antimicrob Agents Chemother
; 56(8): 4331-40, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22664964
14.
Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs.
Antimicrob Agents Chemother
; 56(7): 3726-31, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22547623
15.
Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice.
Am J Respir Crit Care Med
; 183(9): 1254-61, 2011 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21330452
16.
Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
Indian J Med Res
; 136(5): 808-14, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23287128
17.
PA-824 exhibits time-dependent activity in a murine model of tuberculosis.
Antimicrob Agents Chemother
; 55(1): 239-45, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20937781
18.
Activity of the fluoroquinolone DC-159a in the initial and continuation phases of treatment of murine tuberculosis.
Antimicrob Agents Chemother
; 55(4): 1781-3, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21282421
19.
Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infections.
Antimicrob Agents Chemother
; 55(4): 1527-32, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21282447
20.
Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infection.
Antimicrob Agents Chemother
; 55(1): 56-61, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21078940